- Filed
- Mar 20, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2024 · Mar 1, 2025 | 18.66M sh |
| Shares Diluted restated | FY 2024 · Dec 31, 2023 | 1.27M sh |
| Capex restated | FY 2024 · Dec 31, 2023 | $279K |
| Operating Cash Flow restated | FY 2024 · Dec 31, 2023 | −$40.68M |
| Cash And Equivalents restated | FY 2024 · Dec 31, 2023 | $28.77M |
| Current Liabilities restated | FY 2024 · Dec 31, 2023 | $40.89M |
| Total Liabilities restated | FY 2024 · Dec 31, 2023 | $43.41M |
| Current Assets restated | FY 2024 · Dec 31, 2023 | $30.88M |
| Total Assets restated | FY 2024 · Dec 31, 2023 | $39.4M |
| Eps Diluted restated | FY 2024 · Dec 31, 2023 | −$33.76 |
| Eps Basic restated | FY 2024 · Dec 31, 2023 | −$33.76 |
| Rd Expense restated | FY 2024 · Dec 31, 2023 | $36.97M |
| Net Income restated | FY 2024 · Dec 31, 2023 | −$42.82M |
| Operating Income restated | FY 2024 · Dec 31, 2023 | −$44.65M |
| Stockholders Equity restated | FY 2024 · Dec 31, 2022 | −$45.65M |